Fanny C.F. Ip

1.6k total citations
39 papers, 1.1k citations indexed

About

Fanny C.F. Ip is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Fanny C.F. Ip has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Physiology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Fanny C.F. Ip's work include Alzheimer's disease research and treatments (8 papers), Phytochemistry and Biological Activities (6 papers) and Natural product bioactivities and synthesis (5 papers). Fanny C.F. Ip is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Phytochemistry and Biological Activities (6 papers) and Natural product bioactivities and synthesis (5 papers). Fanny C.F. Ip collaborates with scholars based in Hong Kong, China and United Kingdom. Fanny C.F. Ip's co-authors include Nancy Y. Ip, Amy K.Y. Fu, Wing-Yu Fu, Xuhui Huang, Shuo Gu, Kwok‐On Lai, Guangmiao Fu, Yu Pong Ng, Yang Shen and Elaine Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Fanny C.F. Ip

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanny C.F. Ip Hong Kong 21 498 253 237 140 120 39 1.1k
Sarika Singh India 24 465 0.9× 221 0.9× 230 1.0× 116 0.8× 61 0.5× 57 1.4k
Emile Andriambeloson France 18 390 0.8× 143 0.6× 351 1.5× 130 0.9× 124 1.0× 36 1.5k
Jorge Fuentealba Chile 18 394 0.8× 182 0.7× 207 0.9× 109 0.8× 65 0.5× 50 826
Masahiko Watabe Japan 24 1.1k 2.1× 258 1.0× 163 0.7× 132 0.9× 52 0.4× 31 1.8k
Shinghung Mak Hong Kong 22 458 0.9× 209 0.8× 265 1.1× 335 2.4× 81 0.7× 50 1.2k
Yuri Ikeda‐Matsuo Japan 18 408 0.8× 275 1.1× 282 1.2× 342 2.4× 57 0.5× 37 1.3k
Shirlee Tan United States 7 657 1.3× 229 0.9× 160 0.7× 95 0.7× 40 0.3× 9 1.1k
Maria Sapienza Italy 10 655 1.3× 168 0.7× 494 2.1× 105 0.8× 66 0.6× 10 1.4k
Shengquan Hu Hong Kong 21 388 0.8× 175 0.7× 307 1.3× 310 2.2× 73 0.6× 40 1.0k
Xiansi Zeng China 17 558 1.1× 195 0.8× 221 0.9× 65 0.5× 34 0.3× 34 1.1k

Countries citing papers authored by Fanny C.F. Ip

Since Specialization
Citations

This map shows the geographic impact of Fanny C.F. Ip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny C.F. Ip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny C.F. Ip more than expected).

Fields of papers citing papers by Fanny C.F. Ip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny C.F. Ip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny C.F. Ip. The network helps show where Fanny C.F. Ip may publish in the future.

Co-authorship network of co-authors of Fanny C.F. Ip

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny C.F. Ip. A scholar is included among the top collaborators of Fanny C.F. Ip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny C.F. Ip. Fanny C.F. Ip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsui, Joseph, Yuanbing Jiang, Fanny C.F. Ip, et al.. (2025). The TREM2 H157Y variant is associated with more severe neurodegeneration in Alzheimer's disease and altered immune‐related processes. Alzheimer s & Dementia. 21(9). e70586–e70586. 1 indexed citations
2.
Zhong, Huan, Xiaopu Zhou, Yuanbing Jiang, et al.. (2024). Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification. Alzheimer s & Dementia. 20(4). 2469–2484. 9 indexed citations
3.
Zhou, Xiaopu, Fanny C.F. Ip, Yuanbing Jiang, et al.. (2023). Using deep learning models to examine the biological impact of polygenic risks for Alzheimer’s disease. Alzheimer s & Dementia. 19(S1). 1 indexed citations
4.
Wong, Hiu Yi, Huan Zhong, Xiaopu Zhou, et al.. (2022). Demographics and Medication Use of Patients with Late-Onset Alzheimer’s Disease in Hong Kong. Journal of Alzheimer s Disease. 87(3). 1205–1213. 4 indexed citations
5.
Ip, Fanny C.F., et al.. (2021). A tacrine-tetrahydroquinoline heterodimer potently inhibits acetylcholinesterase activity and enhances neurotransmission in mice. European Journal of Medicinal Chemistry. 226. 113827–113827. 5 indexed citations
6.
Jiang, Yuanbing, Xiaopu Zhou, Fanny C.F. Ip, et al.. (2021). Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging. Alzheimer s & Dementia. 18(1). 88–102. 105 indexed citations
7.
Gu, Shuo, Wing‐Yu Fu, Amy K.Y. Fu, et al.. (2018). Identification of new EphA4 inhibitors by virtual screening of FDA-approved drugs. Scientific Reports. 8(1). 7377–7377. 23 indexed citations
8.
9.
Chen, Yuewen, Fanny C.F. Ip, Lei Shi, et al.. (2014). Coronin 6 Regulates Acetylcholine Receptor Clustering through Modulating Receptor Anchorage to Actin Cytoskeleton. Journal of Neuroscience. 34(7). 2413–2421. 35 indexed citations
10.
Ip, Fanny C.F., Yu Pong Ng, Allison C. Chin, et al.. (2014). Cycloastragenol Is a Potent Telomerase Activator in Neuronal Cells: Implications for Depression Management. Neurosignals. 22(1). 52–63. 65 indexed citations
11.
Ip, Fanny C.F., et al.. (2013). Telomerase Inhibition Studies of Novel Spiroketal-Containing Rubromycin Derivatives. Australian Journal of Chemistry. 66(5). 530–533. 10 indexed citations
12.
Hu, Yue‐Qing, et al.. (2012). Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors. Bioorganic & Medicinal Chemistry. 21(3). 676–683. 27 indexed citations
13.
Yung, Lisa Y., Wing Lam, Maurice K.C. Ho, et al.. (2011). Astragaloside IV and Cycloastragenol Stimulate the Phosphorylation of Extracellular Signal-Regulated Protein Kinase in Multiple Cell Types. Planta Medica. 78(2). 115–121. 38 indexed citations
14.
Yu, Hua, et al.. (2011). Intestinal transport of bis(12)‐hupyridone in Caco‐2 cells and its improved permeability by the surfactant Brij‐35. Biopharmaceutics & Drug Disposition. 32(3). 140–150. 27 indexed citations
15.
Zhu, Jing, Stephanie J. Lee, Maurice K.C. Ho, et al.. (2010). In vitro Intestinal Absorption and First-pass Intestinal and Hepatic Metabolism of Cycloastragenol, a Potent Small Molecule Telomerase Activator. Drug Metabolism and Pharmacokinetics. 25(5). 477–486. 29 indexed citations
16.
Long, Jiafu, Wei Feng, Rui Wang, et al.. (2005). Autoinhibition of X11/Mint scaffold proteins revealed by the closed conformation of the PDZ tandem. Nature Structural & Molecular Biology. 12(8). 722–728. 67 indexed citations
17.
Fu, Wing-Yu, et al.. (2002). Induction of Cdk5 activity in rat skeletal muscle after nerve injury. Neuroreport. 13(2). 243–247. 23 indexed citations
18.
Ip, Fanny C.F., et al.. (2001). The expression profiles of neurotrophins and their receptors in rat and chicken tissues during development. Neuroscience Letters. 301(2). 107–110. 52 indexed citations
19.
Lai, Kwok‐On, et al.. (2001). Expression of Eph Receptors in Skeletal Muscle and Their Localization at the Neuromuscular Junction. Molecular and Cellular Neuroscience. 17(6). 1034–1047. 59 indexed citations
20.
Xie, Ping, et al.. (1997). Induction of TrkA receptor by retinoic acid in leukaemia cell lines. Neuroreport. 8(5). 1067–1070. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarika Singh Breakdown of academic impact, for papers by Emile Andriambeloson Breakdown of academic impact, for papers by Jorge Fuentealba Breakdown of academic impact, for papers by Masahiko Watabe Breakdown of academic impact, for papers by Shinghung Mak Breakdown of academic impact, for papers by Yuri Ikeda‐Matsuo Breakdown of academic impact, for papers by Shirlee Tan Breakdown of academic impact, for papers by Maria Sapienza Breakdown of academic impact, for papers by Shengquan Hu Breakdown of academic impact, for papers by Xiansi Zeng
Rankless by CCL
2026